Skip to main content

Table.9 Outcome according to wbTLG 130 g and TNM stage

From: The utility of the standardized uptake value, metabolic tumor volume and total lesion glycolysis as predictive markers of recurrent breast cancer

 

TLG < 130

TLG > 130

p value

TNM stage * wbTLG 130 g cross-tabulation (n = 26)

   

TNM stage

   

 Low

   

  Count

4

0

0.022*

  % of total

15.4%

0.0%

 

 High

   

  Count

7

15

 

  % of total

26.9%

57.7%

 
  1. *Significance level (p < 0.05)